Type II Diabetes
Key concept
- Insulin resistance PLUS insulin deficiency
Definition
- Fasting BSL > 7 mmol/L (normal < 5 mmol/L)
- Random BSL > 11.1 mmol/L + symptoms
- OGTT (at 2 hrs) > 11.1 mmol/L (perform if fasting BSL between 5-7
mmol/L)
- HbA1C > 6.5%
Pathogenesis (multiple factors)
Insulin deficiency
- High fat diet > Altered glucose transport (GLUT-2) into beta cells > v
insulin secretion
- Altered cholesterol transport (Abca1) into beta cells > v insulin
secretion
- v pro-insulin -> insulin in beta cells
- ?v amylin secretion > accumulation of islet amyloid polypeptide (amylin)
> v glucose uptake in beta cells > v insulin secretion
- Various genes related to pancreatic growth, development and insulin
secretion
- Glucokinase mutation > v phosphorylation of glucose > v glucose-6-P > v
insulin secretion (MODY2)
- Insulin promotor factor-1 mutation > v insulin binding > v insulin
secretion (MODY4)
Insulin resistance
- Genetic predisposition to v glucose metabolism & v glycogen storage
(glycogen synthase) & v fatty acid metabolism (post-receptor defects)
- Hypersecretion insulin (initially) > weight gain > chronic
hyperglyceamia > v insulin secretion (vicious cycle)
- 'Adipokines' from adipocytes > insulin resistance
- FFA > v glucose uptake
- Insulin-receptor mutations (rare)
- ?Beta-3 adrenergic receptor mutation
- ?Peroxisome-proliferator-activated receptor (PPAR) mutation > ^ adipose
tissue, v insulin sensitivity
Adipokines
- v Leptin (or resistance) - ^ fat deposition (loss of hypothalamic
endocrine control), v islet cell growth & pancreatic response to ^glucose >
v insulin secretion
- ^ obesity, hyperglycaemia -> v Adiponectin - > ^adipocyte TNFa -> ^
insulin resistance,
- ^ chemokines -> v muscle glucose uptake
Other markers
- ^ resistin -> ^ glucose production
- ^ plasminogen activator inhibitor -> ?
- ^ retinol-binding protein 4 ->
- ^ serum glucose > ^ Interleukin-1 beta islet cell secretion > ?beta cell
dysfunction
- ^ uncoupling protein 2 -> v insulin secretion
- v Obestatin
Drug-induced causes
- Steroids / OCP
- Beta blockers
- Thiazides
- Statins
- Anti-psychotics
Associations
- Upper body obesity
- Chronic inflammation (associated with ^adipokines)
- Novel diabetic Pharmacology
- Pramlintide - amylin analogue
- Thiazolidinediones - PPAR analogues, anti-inflaamtory
- Statins - anti-inflammtory
- Interleukin-1 beta antagonists